Clinical Perspectives

Malignant Hematology ASCO Highlights

Moffitt’s Malignant Hematology physicians and scientists were proud to share and present their research findings at American Society of Clinical...

Gastrointestinal Oncology Presented Research Studies at ASCO 2022

Gastrointestinal oncologists, fellow and radiologists presented exciting findings at ASCO 2022.

Bladder Cancer Treatment Advancement Roundup

At the recent ASCO 2022, there was a lot of excitement about the novel immunotherapy treatment advancements in genitourinary oncology. Learn more...

Gut Microbiome/Metabolome Predicts Response to Immune Checkpoint Blockers in Patients with Recurrent Metastatic Head and Neck Squamous Cell Cancer

Research presented at ASCO demonstrates gut microbial signatures associated with ICB response was found in patients with RM HNSCC.

Phase 1 Dose-Escalation/Expansion Study of CUE-101 Given in Patients with Recurrent/Metastatic HPV16+ Head and Neck Cancer

Escalating doses of CUE-101 monotherapy or in combination with pembrolizumab as evaluated in patients with HPV16+ recurrent/metastatic head and neck...

MRIdian® MRI-Guided Radiation Therapy Shows Positive Results in Treatment of Ultracentral/Central Lung Tumors

Moffitt researchers conducted a study using MRI-guided SBRT/ hypofractionated radiation therapy with image-guided real-time tracking and automatic...

Age is Just a Number When it Comes to Hematopoietic Cell Transplantation for Myelodysplastic Syndromes

Moffitt Cancer Center has the largest and most active blood and marrow transplant program of its kind in Florida and the Southeast

Improving Brain Metastases Outcomes Through Stereotactic Radiosurgery and Immunotherapies

Stereotactic radiosurgery has been a mainstay of treatment for brain metastases and recent advances in targeted therapies and immunotherapies have...

Age-Related Disparity in Treatment Outcome Among Patients with Metastatic Colorectal Cancer

Dr. Hao Xie, MD, an associate member of the Department of Gastrointestinal Oncology, presents his research on age-related health disparities in young...

New Non-Small Cell Lung Cancer Biomarkers Found

New non-small cell lung cancer biomarker: Distinct ecologies exist between disease that does and does not progress.

Neoadjuvant Therapy Proves Effective in Muscle Invasive Bladder Cancer

Erma Wilson Muldrow, a patient at Moffitt, is thankful after she was enrolled in a phase 1 study involving neoadjuvant therapy to treat bladder...

Methylthioadenosine Phosphorylase (MTAP) Pathway for Genitourinary Cancers

There are several options currently available for the initial treatment of prostate, bladder, and kidney cancer.  However, there’re limited resources...

Radiation Oncologist Relates to Cancer Patients 'More Than They Know'

Dr. Roberto Diaz was the section head for Breast Oncology in the Department of Radiation Oncology when he was diagnosed with kidney cancer.

FDA Approves Targeted Radioligand Therapy for Treatment of Advanced Prostate Cancer

The FDA approval of Pluvicto™ is welcome news and an important medical advancement for patients with progressing metastatic castration-resistant...

Sarcoma is Not a Single Disease, There are Actually More Than 70 Subtypes

Sarcoma is a relatively rare type of cancer, accounting for only about 1% of all malignancies in the U.S. Learn more about the types of sarcoma here.